| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:70829 | 6480464 | PLD1 protein promotes the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | CTD | PMID:15210717 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:70829 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLD1 mRNA | CTD | PMID:22079256 |
| (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:70829 | 6480464 | epigallocatechin gallate results in increased expression of PLD1 mRNA | CTD | PMID:22079256 |
| (S)-nicotine | decreases expression | ISO | RGD:70829 | 6480464 | Nicotine results in decreased expression of PLD1 mRNA | CTD | PMID:18247414 |
| 17beta-estradiol | increases expression | ISO | RGD:70829 | 6480464 | Estradiol results in increased expression of PLD1 mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | multiple interactions | ISO | RGD:70829 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PLD1 mRNA | CTD | PMID:19619570 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | increases activity | EXP | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased activity of PLD1 protein | CTD | PMID:17427178 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:70829 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PLD1 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:70829 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PLD1 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:70830 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PLD1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:70829 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PLD1 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:70829 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PLD1 mRNA | CTD | PMID:19619570 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of PLD1 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of PLD1 mRNA | CTD | PMID:21346803 |
| 2-naphthylamine | decreases expression | ISO | RGD:70829 | 6480464 | 2-Naphthylamine results in decreased expression of PLD1 mRNA | CTD | PMID:18247414 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:70830 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of PLD1 mRNA | CTD | PMID:18648102 |
| 5-aza-2'-deoxycytidine | affects expression | ISO | RGD:70829 | 6480464 | decitabine affects the expression of PLD1 mRNA | CTD | PMID:17145863 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:70829 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of and results in increased activity of PLD1 protein; more ... | CTD | PMID:17065600 |
| actinomycin D | multiple interactions | ISO | RGD:70829 | 6480464 | PLD1 protein inhibits the reaction [Dactinomycin results in increased cleavage of PARP1 protein]; more ... | CTD | PMID:14640974 |
| aflatoxin B1 | increases expression | ISO | RGD:70829 | 6480464 | Aflatoxin B1 results in increased expression of PLD1 mRNA | CTD | PMID:21641981 |
| all-trans-retinoic acid | increases expression | ISO | RGD:70829 | 6480464 | Tretinoin results in increased expression of PLD1 mRNA | CTD | PMID:16249480 |
| all-trans-retinoic acid | increases expression | ISO | RGD:70829 | 6480464 | Tretinoin results in increased expression of PLD1 mRNA | CTD | PMID:16249480 PMID:21934132 |
| all-trans-retinoic acid | increases expression | ISO | RGD:70829 | 6480464 | Tretinoin results in increased expression of PLD1 mRNA | CTD | PMID:21934132 PMID:16249480 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PLD1 mRNA | CTD | PMID:16483693 |
| benzene | multiple interactions | EXP | | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of PLD1 mRNA | CTD | PMID:17905399 |
| benzo[a]pyrene | increases expression | ISO | RGD:70829 | 6480464 | Benzo(a)pyrene results in increased expression of PLD1 mRNA | CTD | PMID:17879257 |
| benzo[a]pyrene | decreases expression | ISO | RGD:70829 | 6480464 | Benzo(a)pyrene results in decreased expression of PLD1 mRNA | CTD | PMID:18247414 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:70830 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of PLD1 mRNA | CTD | PMID:21715664 |
| bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of PLD1 protein | CTD | PMID:21079920 |
| bisphenol A | decreases expression | ISO | RGD:70829 | 6480464 | bisphenol A results in decreased expression of PLD1 mRNA | CTD | PMID:20678512 |
| butan-1-ol | multiple interactions | ISO | RGD:70830 | 6480464 | [1-Butanol results in decreased activity of PLD1 protein] which affects the localization of APP protein | CTD | PMID:16449385 |
| butan-1-ol | decreases activity | ISO | RGD:70830 | 6480464 | 1-Butanol results in decreased activity of PLD1 protein | CTD | PMID:19284563 |
| butan-1-ol | decreases activity | EXP | | 6480464 | 1-Butanol results in decreased activity of PLD1 protein | CTD | PMID:15652502 PMID:18344600 |
| butan-1-ol | decreases activity | EXP | | 6480464 | 1-Butanol results in decreased activity of PLD1 protein | CTD | PMID:18344600 PMID:15652502 |
| butan-1-ol | multiple interactions | EXP | | 6480464 | [1-Butanol inhibits the reaction [PRKCA protein binds to PLD1 protein]] which results in decreased activity of PLD1 protein | CTD | PMID:15652502 |
| butan-1-ol | multiple interactions | EXP | | 6480464 | 1-Butanol inhibits the reaction [PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein]]; more ... | CTD | PMID:11243883 |
| butan-1-ol | decreases activity | ISO | RGD:70830 | 6480464 | 1-Butanol results in decreased activity of PLD1 protein | CTD | PMID:16449385 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:70830 | 6480464 | Ciguatoxins affects the expression of PLD1 mRNA | CTD | PMID:18353800 |
| cisplatin | increases expression | ISO | RGD:70830 | 6480464 | Cisplatin results in increased expression of PLD1 mRNA | CTD | PMID:21151649 |
| clofibrate | decreases expression | ISO | RGD:70830 | 6480464 | Clofibrate results in decreased expression of PLD1 mRNA | CTD | PMID:17585979 |
| cobalt dichloride | increases activity | ISO | RGD:70829 | 6480464 | cobaltous chloride results in increased activity of PLD1 protein | CTD | PMID:17640750 |
| cobalt dichloride | multiple interactions | ISO | RGD:70829 | 6480464 | Acetylcysteine inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]]; more ... | CTD | PMID:17640750 |
| copper(2+) sulfate | decreases expression | ISO | RGD:70829 | 6480464 | Copper Sulfate results in decreased expression of PLD1 mRNA | CTD | PMID:19549813 |
| crocidolite asbestos | affects expression | ISO | RGD:70829 | 6480464 | Asbestos, Crocidolite affects the expression of PLD1 mRNA | CTD | PMID:17331233 |
| cyclosporin A | decreases expression | ISO | RGD:70829 | 6480464 | Cyclosporine results in decreased expression of PLD1 mRNA | CTD | PMID:20106945 |
| diazoxide | increases expression | ISO | RGD:70830 | 6480464 | Isoproterenol results in increased expression of PLD1 mRNA | CTD | PMID:20003209 |
| dibutyl phthalate | increases expression | ISO | RGD:70830 | 6480464 | Dibutyl Phthalate results in increased expression of PLD1 mRNA | CTD | PMID:21266533 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of PLD1 mRNA | CTD | PMID:21551480 |
| genistein | multiple interactions | EXP | | 6480464 | Genistein inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of PLD1 protein] | CTD | PMID:15150437 |
| Goe 6976 | multiple interactions | EXP | | 6480464 | Go 6976 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of PLD1 protein] | CTD | PMID:15150437 |
| hydrogen peroxide | affects expression | ISO | RGD:70829 | 6480464 | Hydrogen Peroxide affects the expression of PLD1 mRNA | CTD | PMID:20044591 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | Genistein inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of and results in increased activity of PLD1 protein]; more ... | CTD | PMID:15150437 |
| isoprenaline | increases expression | ISO | RGD:70830 | 6480464 | Isoproterenol results in increased expression of PLD1 mRNA | CTD | PMID:20003209 |
| lysophosphatidic acid | multiple interactions | EXP | | 6480464 | 1-Butanol inhibits the reaction [PLD1 protein affects the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein]]; more ... | CTD | PMID:11243883 |
| lysophosphatidic acid | multiple interactions | EXP | | 6480464 | toxB protein, Clostridium difficile inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of PLD1 protein] | CTD | PMID:14769825 |
| lysophosphatidic acid | increases activity | EXP | | 6480464 | lysophosphatidic acid results in increased activity of PLD1 protein | CTD | PMID:11243883 |
| mercury atom | increases phosphorylation | ISO | RGD:70830 | 6480464 | Mercury results in increased phosphorylation of PLD1 protein | CTD | PMID:21994240 |
| mercury(0) | increases phosphorylation | ISO | RGD:70830 | 6480464 | Mercury results in increased phosphorylation of PLD1 protein | CTD | PMID:21994240 |
| methylmercury(1+) | multiple interactions | EXP | | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of PLD1 mRNA | CTD | PMID:17905399 |
| mifepristone | increases expression | ISO | RGD:70829 | 6480464 | Mifepristone results in increased expression of PLD1 mRNA | CTD | PMID:17584828 |
| mono(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of PLD1 mRNA | CTD | PMID:16809437 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:70829 | 6480464 | Acetylcysteine inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | CTD | PMID:17640750 |
| N-formyl-L-methionyl-L-leucyl-L-phenylalanine | multiple interactions | ISO | RGD:70829 | 6480464 | PLD1 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of MAPK3 protein]; more ... | CTD | PMID:11427526 |
| N-formyl-L-methionyl-L-leucyl-L-phenylalanine | multiple interactions | EXP | | 6480464 | PLD1 protein affects the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Reactive Oxygen Species] | CTD | PMID:17560994 |
| paracetamol | decreases expression | ISO | RGD:70829 | 6480464 | Acetaminophen results in decreased expression of PLD1 mRNA | CTD | PMID:21420995 |
| perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of PLD1 mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of PLD1 mRNA | CTD | PMID:19162173 |
| phenobarbital | affects expression | ISO | RGD:70830 | 6480464 | Phenobarbital affects the expression of PLD1 mRNA | CTD | PMID:23091169 |
| phorbol 13-acetate 12-myristate | increases activity | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of PLD1 protein | CTD | PMID:15067002 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | toxB protein, Clostridium difficile inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of PLD1 protein] | CTD | PMID:14769825 |
| pirinixic acid | multiple interactions | ISO | RGD:70830 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PLD1 mRNA | CTD | PMID:19710929 |
| propiconazole | increases expression | ISO | RGD:70830 | 6480464 | propiconazole results in increased expression of PLD1 mRNA | CTD | PMID:21278054 |
| prostaglandin E2 | multiple interactions | ISO | RGD:70829 | 6480464 | PLD1 protein promotes the reaction [cobaltous chloride results in increased abundance of Dinoprostone] | CTD | PMID:17640750 |
| quercetin | decreases expression | ISO | RGD:70829 | 6480464 | Quercetin results in decreased expression of PLD1 mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | ISO | RGD:70829 | 6480464 | resveratrol results in decreased activity of [C5 protein results in increased localization of and results in increased activity of PLD1 protein] | CTD | PMID:19284563 |
| tetracycline | increases expression | ISO | RGD:70830 | 6480464 | Tetracycline results in increased expression of PLD1 mRNA | CTD | PMID:16917069 |
| topiramate | increases expression | EXP | | 6480464 | topiramate results in increased expression of PLD1 mRNA | CTD | PMID:16979414 |
| trans-resveratrol | multiple interactions | ISO | RGD:70829 | 6480464 | resveratrol results in decreased activity of [C5 protein results in increased localization of and results in increased activity of PLD1 protein] | CTD | PMID:19284563 |
| trichloroethene | multiple interactions | EXP | | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of PLD1 mRNA | CTD | PMID:17905399 |
| troglitazone | increases expression | ISO | RGD:70829 | 6480464 | troglitazone results in increased expression of PLD1 mRNA | CTD | PMID:19140230 |
| valproic acid | affects expression | ISO | RGD:70830 | 6480464 | Valproic Acid affects the expression of PLD1 mRNA | CTD | PMID:17963808 |